The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma
The European respiratory journal(2023)
Abstract
Tweetable abstract
Frequent use of oral corticosteroids can lead to adverse consequences, including weight gain. Treatment with steroid-sparing anti-IL5/5R biologic therapies for severe asthma is associated with significant weight loss in obese patients.https://bit.ly/3PyWRYjTranslated text
Key words
asthma,obese individuals,weight loss,biologic therapies,steroid-sparing
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined